Determining serotonin and dopamine uptake rates in synaptosomes using high- speed chronoamperometry

Electrochemical Methods for Neuroscience

Volumn , Issue , 2006, Pages 103-124

  Perez, Xiomara A ^a   Bressler, Amanda J ^a   Andrews, Anne Milasincic ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84978655968     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (103)

1. Hawley, M. D., Tatawawadi, S. V., Piekarski, S., and Adams, R. N., Electrochemical studies of the oxidation pathways of catecholamines, J. Am. Chem. Soc., 89, 447, 1967.
2. Adams, R. N., Probing brain chemistry with electroanalytical techniques, Anal. Chem., 48, 1126A, 1976.
3. Salamone, J. D., Lindsay, W. S., Neill, D. B., and Justice, J. B., Behavioral observation and intracerebral electrochemical recording following administration of amphetamine in rats, Pharmacol. Biochem. Behav., 17, 445, 1982.
4. Schenk, J. O., Miller, E., Rice, M. E., and Adams, R. N., Chronoamperometry in brain slices: quantitative evaluations of in vivo electrochemistry, Brain Res., 277, 1, 1983.
5. Blakely, R. D. and Duvarney, R. C., A microcomputer controlled system for monitoring multiple voltammetric electrodes in vivo, Brain Res. Bull., 10, 315, 1983.
6. Hefti, F. and Felix, D., Chronoamperometry in vivo: does it interfere with spontaneous neuronal activity in the brain?, J. Neurosci. Methods, 7, 151, 1983.
7. Stamford, J. A. and Justice, J. B. Jr., Probing brain chemistry, Anal. Chem., 68, 359A, 1996.
8. Mosharov, E. V. and Sulzer, D., Analysis of exocytotic events recorded by amperometry, Nat. Methods, 2, 651, 2005.
9. Schenk, J. O., Wright, C., and Bjorklund, N., Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry, J. Neurosci. Methods, 143, 41, 2005.
10. Robinson, D. L., Venton, B. J., Heien, M. L., and Wightman, R. M., Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo, Clin. Chem., 49, 1763, 2003.
11. Troyer, K. P., Heien, M. L., Venton, B. J., and Wightman, R. M., Neurochemistry and electroanalytical probes, Curr. Opin. Chem. Biol., 6, 696, 2002.
12. Daws, L. C., Montanez, S., Owens, W. A., Gould, G. G., Frazer, A., Toney, G. M., and Gerhardt, G. A., Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry, J. Neurosci. Methods, 143, 49, 2005.
13. Michael, D. J. and Wightman, R. M., Electrochemical monitoring of biogenic amine neurotransmission in real time, J. Pharm. Biomed. Anal., 19, 33, 1999.
14. Jones, S. R., Gainetdinov, R. R., and Caron, M. G., Application of microdialysis and voltammetry to assess dopamine functions in genetically altered mice: correlation with locomotor activity, Psychopharmacology (Berl), 147, 30, 1999.
15. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., and Caron, M. G., Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature, 379, 606, 1996.
16. Unger, E. L., Eve, D. J., Perez, X. A., Reichenbach, D. K., Xu, Y., Lee, M. K., and Andrews, A. M., Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice, Neurobiol. Dis., 21, 431, 2006.
17. Phillips, P. E., Stuber, G. D., Heien, M. L., Wightman, R. M., and Carelli, R. M., Subsecond dopamine release promotes cocaine seeking, Nature, 422, 614, 2003.
18. Daws, L. C., Toney, G. M., Davis, D. J., Gerhardt, G. A., and Frazer, A., In vivo chronoamperometric measurements of the clearance of exogenously applied serotonin in the rat dentate gyrus, J. Neurosci. Methods, 78, 139, 1997.
19. Daws, L. C., Toney, G. M., Gerhardt, G. A., and Frazer, A., In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters, J. Pharmacol. Exp. Ther., 286, 967, 1998.
20. Daws, L. C., Gerhardt, G. A., and Frazer, A., 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus, Neurosci. Lett., 266, 165, 1999.
21. Bunin, M. A. and Wightman, R. M., Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission, J. Neurosci., 18, 4854, 1998.
22. Bunin, M. A., Prioleau, C., Mailman, R. B., and Wightman, R. M., Release and uptake rates of 5-hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain, J. Neurochem., 70, 1077, 1998.
23. Jackson, B. P. and Wightman, R. M., Dynamics of 5-hydroxytryptamine released from dopamine neurons in the caudate putamen of the rat, Brain Res., 674, 163, 1995.
24. Jackson, B. P., Dietz, S. M., and Wightman, R. M., Fast-scan cyclic voltammetry of 5-hydroxytryptamine, Anal. Chem., 67, 1115, 1995.
25. Hornykiewicz, O., Biochemical aspects of Parkinson’s disease, Neurology, 51, S2, 1998.
26. Sharma, S. K. and Carew, T. J., The roles of MAPK cascades in synaptic plasticity and memory in Aplysia: facilitatory effects and inhibitory constraints, Learn Mem., 11, 373, 2004.
27. Lesch, K. P., Zeng, Y., Reif, A., and Gutknecht, L., Anxiety-related traits in mice with modified genes of the serotonergic pathway, Eur. J. Pharmacol., 480, 185, 2003.
28. Murphy, D. L., Li, Q., Engel, S., Wichems, C., Andrews, A., Lesch, K. P., and Uhl, G., Genetic perspectives on the serotonin transporter, Brain Res. Bull., 56, 487, 2001.
29. Murphy, D. L., Andrews, A. M., Wichems, C. H., Li, Q., Tohda, M., and Greenberg, B., Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs, J. Clin. Psychiatry, 59, 4, 1998.
30. Uhl, G. R., Hall, F. S., and Sora, I., Cocaine, reward, movement and monoamine transporters, Mol. Psychiatry, 7, 21, 2002.
31. Blakely, R. D., De Felice, L. J., and Hartzell, H. C., Molecular physiology of norepinephrine and serotonin transporters, J. Exp. Biol., 196, 263, 1994.
32. Sheehan, D. V., Current concepts in the treatment of panic disorder, J. Clin. Psychiatry, 60 (suppl. 18), 16, 1999.
33. Liebowitz, M. R., Update on the diagnosis and treatment of social anxiety disorder, J. Clin. Psychiatry, 60 (suppl. 18), 22, 1999.
34. Goodman, W. K., Obsessive-compulsive disorder: diagnosis and treatment, J. Clin. Psychiatry, 60 (suppl. 18), 27, 1999.
35. Keller, M. B., The long-term treatment of depression, J. Clin. Psychiatry, 60 (suppl. 17), 41, 1999.
36. Gough, B., Imam, S. Z., Blough, B., Slikker, W. Jr., and Ali, S. F., Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study, Ann. N. Y. Acad. Sci., 965, 410, 2002.
37. Callaway, C. W., Wing, L. L., and Geyer, M. A., Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats, J. Pharmacol. Exp. Ther., 254, 456, 1990.
38. Bengel, D., Murphy, D. L., Andrews, A. M., Wichems, C. H., Feltner, D., Heils, A., Mossner, R., Westphal, H., and Lesch, K. P., Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (“Ecstasy”) in serotonin transporter-deficient mice, Mol. Pharmacol., 53, 649, 1998.
39. Sora, I., Hall, F. S., Andrews, A. M., Itokawa, M., Li, X. F., Wei, H. B., Wichems, C., Lesch, K. P., Murphy, D. L., and Uhl, G. R., Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference, Proc. NatlAcad. Sci. U.S.A., 98, 5300, 2001.
40. Frazer, A., Antidepressants, J. Clin. Psychiatry, 58 (suppl. 6), 9, 1997.
41. Frazer, A., Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies, J. Clin. Psychiatry, 62 (suppl. 12), 16, 2001.
42. Benmansour, S., Owens, W. A., Cecchi, M., Morilak, D. A., and Frazer, A., Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter, J. Neurosci., 22, 6766, 2002.
43. Fuller, R. W., Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis, Life Sci., 55, 163, 1994.
44. Nestler, E. J., Antidepressant treatments in the 21st century, Biol. Psychiatry, 44, 526, 1998.
45. Nibuya, M., Nestler, E. J., and Duman, R. S., Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus, J. Neurosci., 16, 2365, 1996.
46. Blier, P. and de Montigny, C., Current advances and trends in the treatment of depression, Trends Pharmacol. Sci., 15, 220, 1994.
47. Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., Bengel, D., and Lesch, K. P., Allelic variation of human serotonin transporter gene expression, J. Neurochem., 66, 2621, 1996.
48. Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H., and Murphy, D. L., Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region, Science, 274, 1527, 1996.
49. Greenberg, B. D., Li, Q., Lucas, F. R., Hu, S., Sirota, L. A., Benjamin, J., Lesch, K. P., Hamer, D., and Murphy, D. L., Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample, Am. J. Med. Genet., 96, 202, 2000.
50. Schinka, J. A., Busch, R. M., and Robichaux-Keene, N., A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety, Mol. Psychiatry, 9, 197, 2004.
51. Osher, Y., Hamer, D., and Benjamin, J., Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs, Mol. Psychiatry, 5, 216, 2000.
52. Sen, S., Burmeister, M., and Ghosh, D., Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits, Am. J. Med. Genet., 127B, 85, 2004.
53. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., and Poulton, R., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene, Science, 301, 386, 2003.
54. Bengel, D., Murphy, D. L., Andrews, A. M., Wichems, C. H., Feltner, D., Heils, A., Mossner, R., Westphal, H., and Lesch, K. P., Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (“Ecstasy”) in serotonin transporter-deficient mice, Mol. Pharmacol., 53, 649, 1998.
55. Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., and Caron, M. G., Profound neuronal plasticity in response to inactivation of the dopamine transporter, Proc. NatlAcad. Sci. U.S.A., 95, 4029, 1998.
56. Xu, F., Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Bohn, L. M., Miller, G. W., Wang, Y. M., and Caron, M. G., Mice lacking the norepinephrine transporter are supersensitive to psychostimulants, Nat. Neurosci., 3, 465, 2000.
57. Holmes, A., Lit, Q., Murphy, D. L., Gold, E., and Crawley, J. N., Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background, Genes Brain Behav., 2, 365, 2003.
58. Holmes, A. and Hariri, A. R., The serotonin transporter gene-linked polymorphism and negative emotionality: placing single gene effects in the context of genetic background and environment, Genes Brain Behav., 2, 332, 2003.
59. Holmes, A., Murphy, D. L., and Crawley, J. N., Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression, Biol. Psychiatry, 54, 953, 2003.
60. Murphy, D. L., Uhl, G. R., Holmes, A., Ren-Patterson, R., Hall, F. S., Sora, I., Detera-Wadleigh, S., and Lesch, K. P., Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders, Genes Brain Behav., 2, 350, 2003.
61. Montanez, S., Owens, W. A., Gould, G. G., Murphy, D. L., and Daws, L. C., Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice, J. Neurochem., 86, 210, 2003.
62. Ghijsen, W. E., Leenders, A. G., and Lopes da Silva, F. H., Regulation of vesicle traffic and neurotransmitter release in isolated nerve terminals, Neurochem. Res., 28, 1443, 2003.
63. Raiteri, L. and Raiteri, M., Synaptosomes still viable after 25 years of superfusion, Neurochem. Res., 25, 1265, 2000.
64. Joyce, O. J., Farmer, M. K., Tipton, K. F., and Porter, R. K., Oxidative phosphorylation by in situ synaptosomal mitochondria from whole brain of young and old rats, J. Neurochem., 86, 1032, 2003.
65. Perez, X. A. and Andrews, A. M., Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice, Anal. Chem., 77, 818, 2005.
66. Perez, X. A., Bianco, L. E., and Andrews, A. M., Filtration disrupts synaptosomes during radiochemical analysis of serotonin uptake: Comparison with chronoamperometry in SERT knockout mice, J. Neurosci. Methods, 154 (1-2), 245-255, 2006.
67. Heils, A., Wichems, C., Mossner, R., Petri, S., Glatz, K., Bengel, D., Murphy, D. L., and Lesch, K. P., Functional characterization of the murine serotonin transporter gene promoter in serotonergic raphe neurons, J. Neurochem., 70, 932, 1998.
68. Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., and Price, D. L., Human alpha-synuclein-harboring familial Parkinson’s diseaselinked Ala-53/Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice, Proc. NatlAcad. Sci. U.S.A., 99, 8968, 2002.
69. Hoffman, A. F. and Gerhardt, G. A., In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions, J. Neurochem., 70, 179, 1998.
70. Gerhardt, G. A., Rapid chronocoulometric measurements of norepinephrine overflow and clearance in CNS tissues, In Neuromethods, Boulton, A., Baker, G., and Adams, R. N., Eds., Humana Press, Inc., Totowa, NJ, p. 117, 1995.
71. Gerhardt, G. A., Oke, A. F., Nagy, G., Moghaddam, B., and Adams, R. N., Nafion-coated electrodes with high selectivity for CNS electrochemistry, Brain Res., 290, 390, 1984.
72. Kawagoe, K. T., Zimmerman, J. B., and Wightman, R. M., Principles of voltammetry and microelectrode surface states, J. Neurosci. Methods, 48, 225, 1993.
73. Hyde, C. E. and Bennett, B. A., Similar properties of fetal and adult amine transporters in the rat brain, Brain Res., 646, 118, 1994.
74. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 1951.
75. Cass, W. A. and Gerhardt, G. A., In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens, J. Neurochem., 65, 201, 1995.
76. Numis, A. L., Unger, E. L., Sheridan, D. L., Chisnell, A. C., and Andrews, A. M., The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(20-aminophenyl)-1,2,3,6-tetrahydropyridine (20-NH(2)-MPTP), Mol. Pharmacol., 66, 718, 2004.
77. Whittaker, V. P., Thirty years of synaptosome research, J. Neurocytol., 22, 735, 1993.
78. Scott, I. D. and Nicholls, D. G., Energy transduction in intact synaptosomes Influence of plasmamembrane depolarization on the respiration and membrane potential of internal mitochondria determined in situ, Biochem. J., 186, 21, 1980.
79. Erecinska, M., Nelson, D., and Silver, I. A., Metabolic and energetic properties of isolated nerve ending particles (synaptosomes), Biochim. Biophys. Acta, 1277, 13, 1996.
80. Earles, C. and Schenk, J. O., Multisubtrate mechanism for the inward transport of dopamine by the human dopamine transporter expressed in HEK cells and its inhibition by cocaine, Synapse, 33, 230, 1999.
81. Earles, C. and Schenk, J. O., Rotating disk electrode voltammetric measurements of dopamine transporter activity: an analytical evaluation, Anal. Biochem., 264, 191, 1998.
82. Chen, N. and Justice, J. B. Jr., Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport, J. Neurosci., 18, 10257, 1998.
83. Povlock, S. L. and Schenk, J. O., A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine, J. Neurochem., 69, 1093, 1997.
84. Earles, C., Wayment, H., Green, M., and Schenk, J. O., Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: methodology and mechanistic interpretations, Methods Enzymol., 296, 660, 1998.
85. Richelson, E., Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance, J. Clin. Psychiatry, 64 (suppl. 13), 5, 2003.
86. Habert, E., Graham, D., Tahraoui, L., Claustre, Y., and Langer, S. Z., Characterization of [3H]paroxetine binding to rat cortical membranes, Eur. J. Pharmacol., 118, 107, 1985.
87. Hrdina, P. D., Foy, B., Hepner, A., and Summers, R. J., Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter, J. Pharmacol. Exp. Ther., 252, 410, 1990.
88. Bolden-Watson, C. and Richelson, E., Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes, Life Sci., 52, 1023, 1993.
89. Mathews, T. A., Fedele, D. E., Coppelli, F. M., Avila, A. M., Murphy, D. L., and Andrews, A. M., Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression, J. Neurosci. Methods, 140, 169, 2004.
90. Wise, R. A., Neurobiology of addiction, Curr. Opin. Neurobiol., 6, 243, 1996.
91. Damasio, H., Grabowski, T., Frank, R., Galaburda, A. M., and Damasio, A. R., The return of Phineas Gage: clues about the brain from the skull of a famous patient, Science, 264, 1102, 1994.
92. Coccaro, E. F. and Murphy, D. L., In Serotonin in Major Psychiatric Disorders, Spiegel, D., Ed. Progress in Psychiatry, American Psychiatric Press, Inc, Washington, DC, 1990.
93. O’Reilly, C. A. and Reith, M. E., Uptake of [3H]serotonin into plasma membrane vesicles from mouse cerebral cortex, J. Biol. Chem., 263, 6115, 1988.
94. Reyes-Haro, D., Garcia-Alcocer, G., Miledi, R., and Garcia-Colunga, J., Uptake of serotonin by adult rat corpus callosum is partially reduced by common antidepressants, J. Neurosci. Res., 74, 97, 2003.
95. Fernandez, F., Sarre, S., Launay, J. M., Aguerre, S., Guyonnet-Duperat, V., Moisan, M. P., Ebinger, G., Michotte, Y., Mormede, P., and Chaouloff, F., Rat strain differences in peripheral and central serotonin transporter protein expression and function, Eur J. Neurosci., 17, 494, 2003.
96. Blakely, R. D. and Bauman, A. L., Biogenic amine transporters: regulation in flux, Curr. Opin. Neurobiol., 10, 328, 2000.
97. Zahniser, N. R. and Doolen, S., Chronic and acute regulation of NaC/Cl--dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems, Pharmacol. Ther., 92, 21, 2001.
98. Kruger, R., Muller, T., and Riess, O., Involvement of alpha-synuclein in Parkinson’s disease and other neurodegenerative disorders, J. Neural. Transm., 107, 31, 2000.
99. Mezey, E., Dehejia, A., Harta, G., Papp, M. I., Polymeropoulos, M. H., and Brownstein, M. J., Alpha synuclein in neurodegenerative disorders: murderer or accomplice?, Nat. Med., 4, 755, 1998.
100. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B. et al., Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease, Science, 276, 2045, 1997.
101. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M., Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies, Proc. NatlAcad. Sci. U.S.A., 95, 6469, 1998.
102. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. T., Schols, L., and Riess, O., Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease, Nat. Genet., 18, 106, 1998.
103. Rothman, R. B. and Baumann, M. H., Targeted screening for biogenic amine transporters: potential applications for natural products, Life Sci., 78, 512, 2005.